Alternatives to MacroGenics

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biotechnology company developing novel immunotherapies for cancer.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Global marketplace connecting researchers with human biospecimens for life science research.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

AI-powered platform for antibody discovery and development to create new medicines.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Mabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Teknova provides critical reagents for biopharmaceutical product development and production.

Cloud-native platform for scalable and reproducible bioinformatics workflows.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Mapping cell-cell communication at scale in human tissue.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Developing novel therapeutics for neurodegenerative diseases using advanced biological insights.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Advance every cancer decision.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Global life sciences company providing diagnostic and biopharma laboratory services.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Develops a computational model of the human body for drug discovery and development.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.